Pancreatic Cancer Research

ResearcherSouthern University of Science and TechnologyActive in the last 2 years

Chengmin Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0882-582X; OpenAlex author ID A5077609586. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
3
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. Targeting Prolyl 3-hydroxylase 1 inhibits pancreatic cancer progression and macrophage immunity. First author DOI 10.1038/s41467-026-70452-w↗
  2. Kindlin-2 enhances c-Myc translation through association with DDX3X to promote pancreatic ductal adenocarcinoma progression. Co-author DOI 10.7150/thno.85421↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Panzhu Bai · 2 shared papers, 2023–2026 · strength 0.38
  2. Ying Sun · 2 shared papers, 2023–2026 · strength 0.38
  3. Ruijun Tian · 2 shared papers, 2023–2026 · strength 0.38

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.